Strengths and Limitations
dementia, Alzheimer disease
ADVERSE EFFECTS, ALZHEIMER DISEASE
Our national survey study of physicians had some key strengths. First, the survey used BWS methods to elicit respondent preferences in a complete ranking as compared with Likert scale methods. Second, the survey was conducted and framed around a particularly relevant and vulnerable patient population that is at great risk of adverse effects of polypharmacy. Third, our study focused on primary care for older adults with Alzheimer disease and related dementia, which has been identified as a research priority and clinical need.Given the importance of symptom management as a barrier to deprescribing, there is a need for greater access to nonpharmacological approachesOur study also had several limitations. First, the study was conducted during the COVID-19 pandemic, and this may have influenced physicians’ responses as they relate to the care of individuals living with Alzheimer disease and related dementia. Second, our response rate was in the middle range for contemporary physician surveys, which raises the potential for response bias. However, given similar response rates to other survey studies conducted recently,